Translations:Losartan/32/ja: Difference between revisions

Latest revision as of 22:52, 14 March 2024

Information about message (contribute)

This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.

Message definition (Losartan)

v t e レニン・アンジオテンシン系に作用する降圧薬 (C09)
ACE inhibitor/jas ("-pril")	スルフヒドリル含有: Captopril/ja Rentiapril/ja Zofenopril/ja ジカルボキシレート含有: Enalapril/ja^# Benazepril/ja Cilazapril/ja Delapril/ja Imidapril/ja Lisinopril/ja (+アムロジピン, +HCT) Moexipril/ja Perindopril/ja (+インダパミド) Quinapril/ja (+HCT) Ramipril/ja Spirapril/ja Temocapril/ja Trandolapril/ja ホスホン酸塩含有: Ceronapril/ja Fosinopril/ja (+HCT) その他／グループ外: Alacepril/ja
AIIRA ("-sartan")	Azilsartan/ja Candesartan/ja Eprosartan/ja Fimasartan/ja Irbesartan/ja (+HCT) ロサルタン (+HCT) Olmesartan/ja (+アムロジピン, +アムロジピンと HCT, +HCT) Tasosartan/ja^§ テルミサルタン (+アムロジピン, +HCT) Valsartan/ja (+アムロジピン, +アムロジピンと HCT, +HCT, +ネビボロール)
Renin inhibitor/ja ("-kiren")	Aliskiren/ja (+アムロジピン, +HCT, +アムロジピンと HCT) Remikiren/ja^§
デュアル ACE/NEP 阻害薬	Gemopatrilat/ja Ilepatril/ja Omapatrilat/ja Sampatrilat/ja
Neprilysin/ja 阻害薬	Sacubitril/ja (+バルサルタン)
^#WHO-EM ^‡Withdrawn from market Clinical trials: ^†Phase III ^§Never to phase III

Translations:Losartan/32/ja: Difference between revisions

Latest revision as of 22:52, 14 March 2024

Navigation menu

Search